{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:42:47Z","timestamp":1791142967731,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1124\/jpet.110.166710","type":"journal-article","created":{"date-parts":[[2010,3,4]],"date-time":"2010-03-04T02:01:02Z","timestamp":1267668062000},"page":"632-638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Behavioral Indices in Antipsychotic Drug Discovery"],"prefix":"10.1016","volume":"333","author":[{"given":"Roger D.","family":"Porsolt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Castagn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.110.166710_bib1","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/sj.npp.1301015","article-title":"Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade","volume":"31","author":"Auclair","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.110.166710_bib2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0091-3057(00)00409-3","article-title":"Effects of MK801 and neuroleptics on prepulse inhibition: re-examination in two strains of rats","volume":"67","author":"Bast","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.110.166710_bib3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.pnpbp.2004.06.019","article-title":"Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity","volume":"28","author":"Becker","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/jpet.110.166710_bib4","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.neuropharm.2004.02.008","article-title":"SSR181507, a putative atypical antipsychotic with dopamine D2 antagonist and 5-HT1A agonist activities: improvement of social interaction deficits induced by phencyclidine in rats","volume":"46","author":"Boulay","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.110.166710_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0893-133X(88)90012-7","article-title":"The current status of the dopamine hypothesis of schizophrenia","volume":"1","author":"Carlsson","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.110.166710_bib6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0193-953X(18)30166-7","article-title":"Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia","volume":"16","author":"Casey","year":"1993","journal-title":"Psychiatr Clin North Am"},{"key":"10.1124\/jpet.110.166710_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1054-3589(08)57010-4","article-title":"Preclinical behavioral models for predicting antipsychotic activity","volume":"57","author":"Castagn\u00e9","year":"2009","journal-title":"Adv Pharmacol"},{"key":"10.1124\/jpet.110.166710_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/278059a0","article-title":"Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months","volume":"278","author":"Clow","year":"1979","journal-title":"Nature"},{"key":"10.1124\/jpet.110.166710_bib9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0022-3565(25)10453-9","article-title":"DuP 734 [1-(cyclopropylmethyl)-4-(2\u2032(4\u2033-fluorophenyl)-2\u2032- oxoethyl)piperidine HBr], a potential antipsychotic agent: preclinical behavioral effects","volume":"263","author":"Cook","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.166710_bib10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1749-6632.1957.tb40763.x","article-title":"Behavioral effects of some psychopharmacological agents","volume":"66","author":"Cook","year":"1957","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.110.166710_bib11","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1016\/S0893-133X(99)00128-1","article-title":"Animal models of negative symptoms: M100907 antagonizes PCP-induced immobility in a forced swim test in mice","volume":"21","author":"Corbett","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.110.166710_bib12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0028-3908(82)90096-X","article-title":"Behavioural and biochemical consequences of persistent overstimulation of mesolimbic dopamine systems in the rat","volume":"21","author":"Costall","year":"1982","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.110.166710_bib13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1196\/annals.1300.020","article-title":"Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia","volume":"1003","author":"Coyle","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1124\/jpet.110.166710_bib14","series-title":"Maniement des M\u00e9dicaments Psychotropes","author":"Deniker","year":"1980"},{"key":"10.1124\/jpet.110.166710_bib15","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/sj.npp.1300772","article-title":"Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic","volume":"30","author":"Depoort\u00e8re","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.110.166710_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00213-007-0774-3","article-title":"Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics","volume":"193","author":"Didriksen","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.110.166710_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0920-9964(02)00168-8","article-title":"Visual object processing in schizophrenia: evidence for an associative agnosic deficit","volume":"59","author":"Gabrovska","year":"2003","journal-title":"Schizophr Res"},{"key":"10.1124\/jpet.110.166710_bib18","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1124\/jpet.107.121715","article-title":"ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models","volume":"322","author":"Gardell","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.166710_bib19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.pnpbp.2003.09.003","article-title":"Animal behavior models of the mechanisms underlying antipsychotic atypicality","volume":"27","author":"Geyer","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/jpet.110.166710_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbr.2007.06.012","article-title":"Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat","volume":"184","author":"Grayson","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.110.166710_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00426838","article-title":"Haloperidol-induced tardive dyskinesia in monkeys","volume":"50","author":"Gunne","year":"1976","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.110.166710_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/BF00411367","article-title":"Continuous avoidance as a base-line for measuring behavioral effects of drugs","volume":"3","author":"Heise","year":"1962","journal-title":"Psychopharmacologia"},{"key":"10.1124\/jpet.110.166710_bib23","series-title":"Animal and Translational Models for CNS Drug Discovery Volume 1: Psychiatric Disorders","first-page":"199","article-title":"Developing new drugs for schizophrenia: from animals to the clinic","author":"Jones","year":"2008"},{"key":"10.1124\/jpet.110.166710_bib24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejphar.2007.09.016","article-title":"Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice","volume":"578","author":"Leite","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.110.166710_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/npp.2008.173","article-title":"Removing obstacles in neuroscience drug discovery: the future path for animal models","volume":"34","author":"Markou","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.110.166710_bib26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1124\/jpet.106.106989","article-title":"WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[ 6,7,1hi]indole]: a novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity","volume":"320","author":"Marquis","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.166710_bib27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00213-002-1240-x","article-title":"Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat","volume":"165","author":"Martin","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.110.166710_bib28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0091-3057(99)00217-8","article-title":"Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats","volume":"65","author":"Martinez","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"issue":"Suppl","key":"10.1124\/jpet.110.166710_bib29","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1007\/BF00442554","article-title":"Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia","volume":"99","author":"Meltzer","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.110.166710_bib30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00213-006-0572-3","article-title":"Acute and chronic effects of ketamine upon human memory: a review","volume":"188","author":"Morgan","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.110.166710_bib31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF00634461","article-title":"Effects of dopamine receptor antagonists on sucrose consumption and preference","volume":"99","author":"Muscat","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.110.166710_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00001756-200302100-00023","article-title":"Effect of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in mice","volume":"14","author":"Nagai","year":"2003","journal-title":"Neuroreport"},{"key":"10.1124\/jpet.110.166710_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s002130051055","article-title":"Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice","volume":"145","author":"O'Neill","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.110.166710_bib34","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/sj.npp.1301291","article-title":"Quetiapine prevents anhedonia induced by acute or chronic stress","volume":"32","author":"Orsetti","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.110.166710_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.npp.1301188","article-title":"SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia","volume":"32","author":"Pichat","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.110.166710_bib36","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1124\/jpet.110.166710_bib37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0091-3057(01)00743-2","article-title":"Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia","volume":"71","author":"Pouzet","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.110.166710_bib38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0149-7634(99)00069-X","article-title":"Animal models of acute drug-induced akathisia - a review","volume":"24","author":"Sachdev","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.110.166710_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1515\/REVNEURO.1999.10.1.59","article-title":"Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity","volume":"10","author":"Sams-Dodd","year":"1999","journal-title":"Rev Neurosci"},{"key":"10.1124\/jpet.110.166710_bib40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bbr.2007.10.012","article-title":"Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats\u2013a preliminary investigation","volume":"187","author":"Snigdha","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.110.166710_bib41","first-page":"343","article-title":"Animal models of neuroleptic-induced acute dystonia","volume":"50","author":"Stewart","year":"1988","journal-title":"Adv Neurol"},{"key":"10.1124\/jpet.110.166710_bib42","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.bjp.0705855","article-title":"Nicotine blocks apomorphine-induced disruption of prepulse inhibition of the acoustic startle in rats: possible involvement of central nicotinic alpha7 receptors","volume":"142","author":"Suemaru","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.110.166710_bib43","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejphar.2008.11.036","article-title":"Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs","volume":"602","author":"Sun","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.110.166710_bib44","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0149-7634(99)00037-8","article-title":"The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?","volume":"23","author":"Wadenberg","year":"1999","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.110.166710_bib45","series-title":"Animal Models in Psychiatry","first-page":"1","article-title":"Methods for assessing the validity of animal models of human psychopathology","author":"Willner","year":"1991"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524458138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524458138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.110.166710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:11:58Z","timestamp":1740017518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524458138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0022356524458138"],"URL":"https:\/\/doi.org\/10.1124\/jpet.110.166710","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioral Indices in Antipsychotic Drug Discovery","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.110.166710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}